Cargando…
Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era
Spinal muscular atrophy (SMA) is a lower motor neuron disease due to biallelic mutations in the SMN1 gene on chromosome 5. It is characterized by progressive muscle weakness of limbs, bulbar and respiratory muscles. The disease is usually classified in four different phenotypes (1–4) according to ag...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679720/ https://www.ncbi.nlm.nih.gov/pubmed/38020652 http://dx.doi.org/10.3389/fneur.2023.1226969 |